14.000
+4,48%
2026-10-19
Fundamental Analysis
96 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +79.7% | +156.2% | 3 / 3 | +28.3% | +13.16 pp | +10.24 pp | +18.4% | 0.22 | 5.39 | 233 | +28,3% | 83,3 | +79,7% | 5.39 | 12.43 | −56,6% |
| Pts | 12 | 12 | 12 | 12 | 12 | 12 | 8 | 12 | 12 | |||||||
Valuation annotation:Price: 14.000 (close price on 2026-10-19)EPS (TTM): 2.598
Financial charts
1.Revenue & growth
VND bn233Q2/26
1.Revenue & growth
VND bn233Q2/26
2.Profit & growth
VND bn84,6Q2/26
3.Profit mix (Penman)
VND bn319Q2/26
4.Margins & cost structure
%31.6%Q2/26
5.Returns & cash cycle
% · days12.4%Q2/26
6.Earnings quality & cash
VND bn283Q2/26
7.Asset structure
VND bn1.978Q2/26
8.Funding & debt health
VND bn · times1.978Q2/26
9.Revenue backlog
VND bn16,0Q2/26
10.Valuation
times · %5,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %846Q2/26
Adjusted EPS growth, latest quarter
82.6%
Average adjusted EPS growth, 3 quarters
157%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26